Welcome to our dedicated page for Jupiter Wellness SEC filings (Ticker: SHOTW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Jupiter Wellness Inc (SHOTW) sits at the intersection of cannabinoid science and consumer wellness, which means even a single 8-K about a clinical trial result or financing round can move the stock dramatically. If you’re scanning hundreds of pages to confirm FDA feedback on a Canidermrx study or to see how Canisun sales trends migrate through segments, you’re in the right place.
Our platform assembles every filing the moment it hits EDGAR and layers on AI-powered summaries that translate technical language into plain English. Whether you’re hunting for the Jupiter Wellness quarterly earnings report 10-Q filing, need a Jupiter Wellness annual report 10-K simplified, or want Jupiter Wellness 8-K material events explained, the key points appear upfront—cash burn, R&D commitments, and regulatory milestones included.
Dig deeper with real-time alerts on Jupiter Wellness insider trading Form 4 transactions. See patterns through our “Jupiter Wellness Form 4 insider transactions real-time” feed, monitor dilution risk from S-1s, or compare option grants via the latest Jupiter Wellness proxy statement executive compensation. Need quick context? Select “understanding Jupiter Wellness SEC documents with AI” for an instant walkthrough and concise Jupiter Wellness earnings report filing analysis. From financing covenants to Jupiter Wellness executive stock transactions Form 4, every disclosure is cataloged, summarized, and linked so you can make decisions swiftly, not sift through jargon.
Safety Shot, Inc. reported interim results showing rapid equity and transaction activity alongside liquidity strain. The company had 101,725,935 common shares issued and outstanding as of June 30, 2025 and reported a fair value of marketable SRM shares of $18.2 million (2,347,142 shares) subject to a lock-up through January 2026. The company completed the acquisition of Yerbaé by issuing 19,881,948 shares as part of approximately $6.0 million total consideration.
Material liquidity concerns were disclosed: negative working capital of $3,016,005 and $6,816,954 (periods noted) and the absence of cash equivalents, which the company says raises substantial doubt about its ability to continue as a going concern. Subsequent financing transactions closed after period end (RD and PIPE offerings closed July 24, 2025) raising gross proceeds of about $16.3 million before offering expenses.
FAQ
What is the current stock price of Jupiter Wellness (SHOTW)?
